23.98 Up +0.37 +1.57%
Find StockScouter ratings for:
ACADIA PHARMACEUTICALS INC: STOCK RATING SUMMARY
5
StockScouter

ACADIA PHARMACEUTICALS Inc, a mid-cap unknown style company in the health care sector, is expected to outperform the market over the next six months with above average risk.

10 is the best possible rating.

QUICK SUMMARY
Pro

The StockScouter measure of relative price change and consistency is very high. Very positive

Previous day's closing price for ACAD was slightly above its 50-day moving average. Positive

Con

The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative

The price-to-earnings multiple is a negative number. No effect

FUNDAMENTAL
Grade: D

The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative

Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative

One or more analysts has modestly decreased quarterly earnings estimates for ACAD. Negative

OWNERSHIP
Grade: C

A high-level executive sold a small number of shares recently. This tends to be a neutral to bad sign. Neutral/Negative

Shares are under heavy accumulation by financial institutions. Positive for large companies like ACAD

VALUATION
Grade: D

The price-to-earnings multiple is a negative number. No effect

Price-to-sales information is unavailable or inconsistent.

The ratio of ACAD's price-to-earnings multiple to its five-year growth rate is unavailable or inconsistent.

TECHNICAL
Grade: A

The StockScouter measure of relative price change and consistency is very high. Very positive

Previous day's closing price for ACAD was slightly above its 50-day moving average. Positive

StockScouter data provided by Verus Analytics

Verus Analytics, Inc.

Learn more about the StockScouter rating system.

Page generated 9/01/2014 7:39 AM ET

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.